Chronic Kidney Disease III: Interprofessional Care

• Understand the collaborative framework of chronic kidney disease III interprofessional care and how healthcare teams coordinate treatment strategies
• Identify key diagnostic markers including glomerular filtration rate (GFR) ranges of 30-59 mL/min/1.73m² and early warning signs like proteinuria
• Analyze medical management protocols including ACE inhibitors, ARBs, and hyperkalemia treatment approaches used by healthcare teams
• Compare dialysis modalities (hemodialysis, peritoneal dialysis, CRRT) and their appropriate clinical applications
• Evaluate nutrition therapy guidelines that differ between non-dialysis (0.6-1.0 g/kg/day protein) and dialysis patients (1.2-1.3 g/kg/day protein)
• Apply emergency hyperkalemia management using calcium gluconate for cardiac stabilization and insulin for cellular potassium uptake
• Recognize imaging study roles including renal ultrasound for structural assessment and CT scans for stone detection
• Explore the decision-making process for initiating renal replacement therapy based on clinical indicators

Understanding Chronic Kidney Disease III Interprofessional Care Framework

Chronic kidney disease stage III represents a critical juncture where kidney function declines to 30-59% of normal capacity, requiring coordinated interprofessional management. At major US medical centers like Johns Hopkins and Mayo Clinic, healthcare teams integrate nephrologists, primary care physicians, pharmacists, dietitians, and social workers to address the complex needs of CKD III patients. This collaborative approach becomes essential because kidney disease affects multiple body systems simultaneously-cardiovascular health, bone metabolism, electrolyte balance, and nutritional status all require specialized attention.

Diagnostic Assessment and Monitoring Protocols

Healthcare teams rely on comprehensive diagnostic approaches that extend beyond basic creatinine measurements. The estimated glomerular filtration rate (eGFR) serves as the primary staging tool, with CKD III defined as eGFR between 30-59 mL/min/1.73m². Proteinuria detection through urine albumin-to-creatinine ratio provides early intervention opportunities, often appearing years before significant GFR decline. Advanced imaging plays crucial roles: renal ultrasounds assess kidney size and detect obstructions, while CT scans identify stones, masses, or structural abnormalities. In complex cases, kidney biopsies help diagnose specific conditions like glomerulonephritis or diabetic nephropathy, guiding targeted treatment strategies.

Pharmacological Management and Team Coordination

Medical management centers on slowing disease progression through evidence-based interventions. ACE inhibitors and angiotensin receptor blockers (ARBs) serve as first-line treatments, providing both blood pressure control and nephroprotective effects by reducing intraglomerular pressure. Pharmacists play vital roles in medication reconciliation, ensuring proper dosing adjustments as kidney function declines. Hyperkalemia management requires coordinated responses: dietary potassium restrictions implemented by dietitians, chronic management with medications like patiromer, and emergency protocols using calcium gluconate for cardiac protection and insulin-glucose combinations for rapid potassium redistribution.

Nutritional Interventions and Lifestyle Modifications

Dietitians provide specialized guidance that differs significantly between disease stages and treatment modalities. Non-dialysis CKD III patients typically follow protein-restricted diets (0.6-1.0 g/kg/day) to reduce uremic toxin production while maintaining adequate nutrition. This contrasts sharply with dialysis patients who require increased protein intake (1.2-1.3 g/kg/day) to compensate for dialysis-related losses. Phosphorus and potassium restrictions become increasingly important as GFR declines, with dietitians educating patients about hidden sources in processed foods-knowledge particularly relevant for NCLEX and nursing school examinations focusing on therapeutic nutrition principles.